Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Valeant Pharmaceuticals Intl (VRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,120,787
  • Shares Outstanding, K 348,590
  • Annual Sales, $ 9,674 M
  • Annual Income, $ -2,409,000 K
  • 36-Month Beta -0.40
  • Price/Sales 0.52
  • Price/Cash Flow 1.02
  • Price/Book 0.92

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.94 +34.28%
on 11/02/17
15.74 -6.67%
on 11/10/17
+1.88 (+14.68%)
since 10/17/17
3-Month
10.94 +34.28%
on 11/02/17
15.74 -6.67%
on 11/10/17
+0.35 (+2.44%)
since 08/17/17
52-Week
8.31 +76.77%
on 04/24/17
18.65 -21.23%
on 11/22/16
-3.29 (-18.30%)
since 11/17/16

Most Recent Stories

More News
TroyGould Advises Haitong International in its $190 Million Acquisition of Obagi Skincare Products Business

TroyGould advised Haitong International Zhonghua Finance Acquisition Fund I, L.P. (the "Fund") in its $190 million cash acquisition of the Obagi Medical Products business from Valeant Pharmaceuticals International,...

VRX.TO : 18.80 (+2.84%)
VRX : 14.69 (+2.44%)
Valeant (VRX) Announces Pricing of Senior Secured Notes

Valeant (VRX) prices its senior secured notes. The proceeds of the notes will be used to pay down its existing debt.

CORT : 18.39 (-3.46%)
LGND : 140.31 (-0.99%)
SCMP : 10.55 (+1.93%)
VRX : 14.69 (+2.44%)
Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program

First Sponsored Contact Lens Recycling Program Collects More Than 7,000 lbs. of Waste

VRX.TO : 18.80 (+2.84%)
VRX : 14.69 (+2.44%)
Bear of the Day: Herbalife (HLF)

Bear of the Day: Herbalife (HLF)

HLF : 65.67 (+0.32%)
JCP : 3.29 (+4.11%)
CMG : 289.84 (+2.16%)
VRX : 14.69 (+2.44%)
Bear of the Day: Herbalife (HLF)

Bear of the Day: Herbalife (HLF)

HLF : 65.67 (+0.32%)
JCP : 3.29 (+4.11%)
CMG : 289.84 (+2.16%)
VRX : 14.69 (+2.44%)
Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has priced its previously announced offering of $750,000,000 aggregate principal...

VRX.TO : 18.80 (+2.84%)
VRX : 14.69 (+2.44%)
Ortho Dermatologics Announces Aspire Higher Scholarship Honorees

Scholarship Program Awards Students Across the Country Impacted by Dermatologic Conditions

VRX.TO : 18.80 (+2.84%)
VRX : 14.69 (+2.44%)
Valeant Announces Launch of Private Offering of Add-On Secured Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has launched an offering of $750,000,000 aggregate principal amount of 5.500% senior...

VRX.TO : 18.80 (+2.84%)
VRX : 14.69 (+2.44%)
Valeant Announces Launch of Private Offering of Add-On Secured Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has launched an offering of $750,000,000 aggregate principal amount of 5.500% senior...

VRX.TO : 18.80 (+2.84%)
VRX : 14.69 (+2.44%)
Corporate News Blog - Valeant Pharma Completes Sale of its Obagi Medical Products Business

Research Desk Line-up: Bio-Path Post Earnings Coverage

VRX : 14.69 (+2.44%)
BPTH : 0.31 (+6.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. The Company produces medicines that meet the special health problems of patients....

See More

Key Turning Points

2nd Resistance Point 15.07
1st Resistance Point 14.88
Last Price 14.69
1st Support Level 14.39
2nd Support Level 14.09

See More

52-Week High 18.65
Fibonacci 61.8% 14.70
Last Price 14.69
Fibonacci 50% 13.48
Fibonacci 38.2% 12.26
52-Week Low 8.31

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart